Drug Store News

FEBRUARY 21, 2023

generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board. Christine Baeder, senior vice president and chief operating officer for U.S.

105

105

Pharmacy Times

DECEMBER 14, 2023

Seven New Members from Diverse Health Care Professions, Organizations and Industries Join Board

73

73

Drug Store News

SEPTEMBER 13, 2022

Balser also has been named to the board’s medical affairs committee.

104

104

PharmExec

OCTOBER 16, 2023

Executive previously served as chief financial officer of Moderna, Amgen, and 3M.

52

52

STAT

FEBRUARY 2, 2024

Amid ongoing uncertainty about when abortions are permissible in Texas, the state’s medical board is under growing pressure to issue guidance on what type of emergency qualifies for an exemption from the state’s abortion ban. Read the rest…

145

145

pharmaphorum

APRIL 15, 2024

Shah Capital has fired a broadside at the management team of Novavax, seeking a change in leadership at the vaccine company and the appointment of two handpicked directors to the board.

Vaccines 108

Vaccines 108

Fierce Healthcare

APRIL 10, 2024

Banner Health CEO Peter Fine will retire on June 30 after 24 years in the $14 billion system’s top role, according to a Tuesday announcement from its Board of Directors.

Hospitals 98

Hospitals 98

European Pharmaceutical Review

APRIL 29, 2024

The Cell and Gene Therapy Catapult (CGT Catapult) has appointed three new Non-Executive Directors to its board. CGT Catapult’s new board appointments Dr Faulkner’s previous roles include working at companies such as at Apple Tree Partners, Ascidian Therapeutics, Autolus Ltd and GlaxoSmithKline, CGT Catapult shared.

72

72

STAT

APRIL 18, 2024

The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures. Ziff, who is one of the heirs to the Ziff Davis publishing fortune, was sitting on CHOP’s board of trustees.

Vaccines 136

Vaccines Hospitals 136

STAT

JANUARY 3, 2024

Margery Quackenbush was attending a board meeting of the nonprofit where she served as executive director when she felt a sharp, stabbing pain in her chest. As the organization’s president yelled at a board member, Quackenbush — then age 69 — noticed her heart tightening and felt terrified.

142

142

BioPharm

APRIL 17, 2024

At INTERPHEX 2024, Susan Schniepp, distinguished fellow, Regulatory Compliance Associates, and co-chair of board of directors, Parenteral Drug Association, explores the impact of QMS on quality maturity.

69

69

Fierce Pharma

JUNE 13, 2023

Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D., Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D.,

107

107

Fierce Pharma

FEBRUARY 20, 2024

Robert Michael, AbbVie’s current president and chief operating officer, has been tapped by the company’s board of directors to take over Richard Gonzalez’s CEO post on July 1. Gonzalez, for his part, is retiring from his role as chief executive after 11 years to become executive chairman of AbbVie’s board.

88

88

STAT

JUNE 6, 2023

BOSTON — As Biogen’s new CEO Chris Viehbacher pores over Biogen’s books and scouts out M&A deals, he may have one advantage his predecessor didn’t: a good relationship with his board of directors. Continue to STAT+ to read the full story…

109

109

Fierce Pharma

DECEMBER 21, 2023

Along with a new CEO, BioMarin will head into 2024 with three new board directors and a new strategy review committee after settling with activist investor Elliott Investment Management. The three new independent directors include a former Lilly exec and ImmunoGen's CEO.

92

92

STAT

JUNE 29, 2023

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board. The outcome is a setback for Sarissa, which owns 8.5%

98

98

STAT

MARCH 4, 2024

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own.

Hospitals 143

Hospitals FDA 143

Drug Store News

NOVEMBER 27, 2023

In connection with Mallinckrodt's emergence, David Stetson, executive chairman of Alpha Metallurgical Resources, and Jon Zinman, a managing director at Silver Point Capital, have been appointed to the board, effective immediately.

96

96

STAT

FEBRUARY 20, 2024

Gonzalez, 70, will become executive chairman of the board of directors. He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be.

142

142

European Pharmaceutical Review

APRIL 2, 2024

With his proven leadership capabilities, Wolfgang is ideally placed to act as an ambassador for our business and lead our colleague community as Lonza enters the next chapter of its growth journey,” shared Albert Baehny, Chairman of the Board of Directors and CEO ad interim, Lonza. “I billion.

81

81

STAT

OCTOBER 11, 2023

These efforts involve Prescription Drug Affordability Boards, which are designed to function like a rate-setting authority. is only going to escalate further. “So we should be excited about any move that could decrease costs.” ” Continue to STAT+ to read the full story…

127

127

STAT

MAY 24, 2023

A catch-up: Illumina is holding a meeting during which investors will vote on who should be on its board of directors. Carl Icahn, the embodiment of activist investing, has proposed adding three new directors to the board. That means that this is the rare proxy fight that could result in serious change.

98

98

PharmExec

JANUARY 8, 2024

As the use of emerging technologies such as generative artificial intelligence continues to grow to support the innovation goals of Fortune 500 companies, so too does the risk of cybersecurity breaches.

119

119

Pharmacy Times

SEPTEMBER 2, 2022

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacists and pharmacy technicians can advocate for the certification of pharmacy technicians.

PTCB 123

PTCB 123

Pharmacy Times

SEPTEMBER 1, 2022

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.

PTCB 123

PTCB 123

Pharmafile

APRIL 11, 2024

The transaction has been approved by both companies’ board of directors and is expected to close later in the second quarter of 2024. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Immunization 59

Immunization 59

Pharmacy Times

SEPTEMBER 5, 2022

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses why pharmacy technicians are leaving the profession and why they are staying.

PTCB 123

PTCB 123

Pharmafile

APRIL 8, 2024

Both companies’ boards of directors have approved the transaction. Johnson & Johnson (J&J) and Shockwave Medical have announced that they have entered into a definitive agreement under which J&J will acquire all outstanding shares of Shockwave Medical for $335 per share, or a total value of $13.1bn.

59

59

STAT

FEBRUARY 29, 2024

Burow is a managing director at ARCH, where she has been influential in building bold and well-capitalized startups. Burow also sits on the boards of several emerging biotech companies, helping to steer how they stress-test their science and what types of therapies to pursue. Read the rest…

106

106

Drug Store News

MAY 1, 2023

Revlon is looking to emerge from bankruptcy by forming a new board of directors with senior executives of such brands as Sephora, Bloomin’ and Walgreens Boots Alliance

98

98

STAT

JUNE 26, 2023

Biogen shareholders voted to add biotech executive Susan Langer, who is the romantic partner of departing director Alex Denner, to its board of directors on Monday, concluding a weeklong episode that led some investors to question the company’s leadership. Langer, 32, will join the eight-member board for a one-year term.

98

98

Fierce Healthcare

AUGUST 17, 2023

Stanford Health Care CEO David Entwistle joined the board of directors at New York City-based Redesign Health. David Entwistle has a storied career as a healthcare executive leading new innovations and steering strategic growth at academic medical centers. Here are the areas of healthcare he thinks are ripe for innovation.

98

98

Pharmacy Times

JULY 18, 2022

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses how the changing role of pharmacy technicians has also helped the role of the pharmacist.

117

117

Pharmacy Times

JULY 15, 2022

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses more advanced roles for pharmacy technicians and how they can continue to grow beyond their current roles.

123

123

Drug Store News

JANUARY 29, 2024

Beauty is embarking on a partnership with the National Association of Corporate Directors to help organizations assemble diverse and inclusive boards.

59

59

Pharmacy Times

JUNE 30, 2022

Andrea Iannucci, PharmD, BCOP, member of the Board of Directors of the Hematology/Oncology Pharmacy Association (HOPA), discusses some common challenges hematology oncology pharmacists face in the field during their pursuit of professional growth and development.

120

120

Drug Store News

DECEMBER 21, 2022

Hy-Vee CEO Jeremy Gosch was named vice chairman of the board of directors, and executives Donna Tweeten and Aaron Wiese will assume president roles overseeing distinct business areas.

105

105